Previous
Poster Home
Next
Physician Preferences on Biomarker Testing in Newly-Diagnosed metastatic NSCLC Patients Who had Insufficient Tumor Tissue
07:30am - 03:45pm EDT - April 1, 2023
Information
Resources
Play Recording
https://jnccn.org/view/journal...
Author(s):
Anne Shah, PhD
, AstraZeneca Pharmaceuticals, LP
Tags:
Outcomes and Health Services Research
Display Label
Action
093-General Poster Session
Download Resource